Company / EPS (Basic)
Summit Therapeutics Inc. EPS (Basic) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.44
FY2025
5-year range
-$1.44 / -$0.41
FY2021-FY2025
Trend
-251.2%
vs FY2024
Sector context
#104 of 208
Health Care
What the data says
EPS (Basic) changed -251% YoY in FY2025, a notable deviation from the 7-year average annual change of -70%.
Based on SEC 10-K filings.
-1.44 in FY2025.
Declined from $-0.41 to $-1.44 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 208 in Health CareTop 50% of 208This company -$1.44 Sector average -$0.87
▼
-65.4% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 251.2% year-over-year.
- Ranks #104 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.44 | -251.2% |
| FY2024 | -$0.41 | +0.0% |
| FY2023 | -$0.41 | +38.8% |
| FY2022 | -$0.67 | +11.8% |
| FY2021 | -$0.76 | -220.6% |
| FY2020 | $0.63 | +170.8% |
| FY2019 | -$0.89 | -241.3% |
| FY2018 | $0.63 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026